Maria Stendahl

3.0k total citations
19 papers, 732 citations indexed

About

Maria Stendahl is a scholar working on Nephrology, Oncology and Infectious Diseases. According to data from OpenAlex, Maria Stendahl has authored 19 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 7 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Maria Stendahl's work include Dialysis and Renal Disease Management (8 papers), Estrogen and related hormone effects (4 papers) and COVID-19 Clinical Research Studies (4 papers). Maria Stendahl is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Estrogen and related hormone effects (4 papers) and COVID-19 Clinical Research Studies (4 papers). Maria Stendahl collaborates with scholars based in Sweden, Italy and Netherlands. Maria Stendahl's co-authors include Göran Landberg, Lisa Rydén, Karin Jirström, Marie Evans, Åsa Kronblad, Stefan O. Emdin, Helena Rydell, Mårten Segelmark, Nils‐Olof Bengtsson and Per Jönsson and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Maria Stendahl

18 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Stendahl Sweden 11 336 218 217 178 149 19 732
Rosalin Cooper United Kingdom 10 499 1.5× 174 0.8× 292 1.3× 221 1.2× 104 0.7× 24 951
Patrick J. Medina United States 14 210 0.6× 163 0.7× 52 0.2× 45 0.3× 162 1.1× 22 719
Els Vercammen Belgium 10 433 1.3× 103 0.5× 72 0.3× 47 0.3× 104 0.7× 26 1.6k
Nam Sun Paik South Korea 12 447 1.3× 168 0.8× 310 1.4× 151 0.8× 132 0.9× 40 949
Marcel Soesan Netherlands 12 462 1.4× 237 1.1× 59 0.3× 39 0.2× 139 0.9× 23 912
Koki Mise Japan 20 100 0.3× 301 1.4× 74 0.3× 238 1.3× 212 1.4× 83 1.2k
Marie‐Hélène Schlageter France 19 421 1.3× 342 1.6× 78 0.4× 52 0.3× 106 0.7× 39 1.4k
Hayakazu Nakazawa Japan 20 698 2.1× 339 1.6× 107 0.5× 42 0.2× 477 3.2× 64 1.7k
Elisabeth Jones United States 5 280 0.8× 206 0.9× 62 0.3× 47 0.3× 309 2.1× 5 1.0k
Zafer Arık Türkiye 11 290 0.9× 107 0.5× 116 0.5× 46 0.3× 77 0.5× 57 476

Countries citing papers authored by Maria Stendahl

Since Specialization
Citations

This map shows the geographic impact of Maria Stendahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Stendahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Stendahl more than expected).

Fields of papers citing papers by Maria Stendahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Stendahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Stendahl. The network helps show where Maria Stendahl may publish in the future.

Co-authorship network of co-authors of Maria Stendahl

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Stendahl. A scholar is included among the top collaborators of Maria Stendahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Stendahl. Maria Stendahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Segelmark, Mårten, Helena Rydell, Rino Bellocco, et al.. (2025). COVID-19 among kidney transplant recipients: evaluating risk factors during the initial phase of the pandemic. Clinical Kidney Journal. 18(3). sfaf030–sfaf030.
2.
Faucon, Anne‐Laure, Helena Rydell, Maria Stendahl, et al.. (2025). The Swedish Renal Registry: a nationwide registry for chronic kidney disease of all stages. Clinical Kidney Journal. 18(9). sfaf238–sfaf238. 1 indexed citations
3.
Wijkström, Julia, et al.. (2023). Risk factors for COVID-19 hospitalization and mortality in patients with chronic kidney disease: a nationwide cohort study. Clinical Kidney Journal. 17(1). sfad283–sfad283. 8 indexed citations
4.
Wijkström, Julia, Annette Bruchfeld, Maria Stendahl, et al.. (2023). Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19. Nephrology Dialysis Transplantation. 38(11). 2607–2616. 9 indexed citations
5.
Rydell, Helena, et al.. (2021). CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden. American Journal of Kidney Diseases. 78(2). 190–199.e1. 128 indexed citations
6.
Segelmark, Mårten, et al.. (2021). [COVID-19 related mortality in Swedish patients with renal replacement therapy].. PubMed. 118. 2 indexed citations
7.
Holmberg, Erik, Per Lindblad, Maria Stendahl, et al.. (2021). Increased risk for renal cell carcinoma in end stage renal disease – a population-based case-control study. Scandinavian Journal of Urology. 55(3). 209–214. 10 indexed citations
8.
Xu, Hong, Bengt Lindholm, Olof Heimbürger, et al.. (2021). Treatment practices and outcomes in incident peritoneal dialysis patients: the Swedish Renal Registry 2006–2015. Clinical Kidney Journal. 14(12). 2539–2547. 3 indexed citations
9.
Evans, Marie, Hong Xu, Helena Rydell, et al.. (2020). Association between implementation of novel therapies and improved survival in patients starting haemodialysis: the Swedish Renal Registry 2006–15. Nephrology Dialysis Transplantation. 36(7). 1298–1306. 4 indexed citations
10.
Pagels, Agneta A., Maria Stendahl, & Marie Evans. (2019). Patient-reported outcome measures as a new application in the Swedish Renal Registry: health-related quality of life through RAND-36. Clinical Kidney Journal. 13(3). 442–449. 16 indexed citations
11.
Ocak, Gürbey, Marlies Noordzij, Maarten B. Rookmaaker, et al.. (2018). Mortality due to bleeding, myocardial infarction and stroke in dialysis patients. Journal of Thrombosis and Haemostasis. 16(10). 1953–1963. 17 indexed citations
12.
Qureshi, Abdul Rashid, Marie Evans, Maria Stendahl, Karl‐Göran Prütz, & C G Elinder. (2013). The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden--analysis of variations by region over the period 1991-2010. Clinical Kidney Journal. 6(3). 352–357. 7 indexed citations
13.
Evans, Marie, Karlijn J. van Stralen, Staffan Schön, et al.. (2013). Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease. Nephrology Dialysis Transplantation. 28(10). 2518–2526. 41 indexed citations
14.
Stendahl, Maria, Caroline Wigerup, Karin Jirström, et al.. (2010). p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients. International Journal of Cancer. 127(12). 2851–2858. 24 indexed citations
15.
Borgquist, Signe, Caroline Holm, Maria Stendahl, et al.. (2008). Oestrogen receptors α and β show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer. Journal of Clinical Pathology. 61(2). 197–203. 54 indexed citations
16.
Stendahl, Maria, Lisa Rydén, Bo Nordenskjöld, et al.. (2006). High Progesterone Receptor Expression Correlates to the Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer Patients. Clinical Cancer Research. 12(15). 4614–4618. 111 indexed citations
17.
Stendahl, Maria, et al.. (2005). Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response. Breast Cancer Research and Treatment. 89(2). 135–143. 54 indexed citations
18.
Jirström, Karin, Maria Stendahl, Lisa Rydén, et al.. (2005). Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with Cyclin D1 Gene Amplification. Cancer Research. 65(17). 8009–8016. 107 indexed citations
19.
Stendahl, Maria, Åsa Kronblad, Lisa Rydén, et al.. (2004). Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. British Journal of Cancer. 90(10). 1942–1948. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalin Cooper Breakdown of academic impact, for papers by Patrick J. Medina Breakdown of academic impact, for papers by Els Vercammen Breakdown of academic impact, for papers by Nam Sun Paik Breakdown of academic impact, for papers by Marcel Soesan Breakdown of academic impact, for papers by Koki Mise Breakdown of academic impact, for papers by Marie‐Hélène Schlageter Breakdown of academic impact, for papers by Hayakazu Nakazawa Breakdown of academic impact, for papers by Elisabeth Jones Breakdown of academic impact, for papers by Zafer Arık
Rankless by CCL
2026